EFSA Conference 2027: Future Regulatory Shifts for European Supplement Market
EFSA's 2027 'Safe Food, One Future' conference signals a critical review of 25 years of food chain risks, prompting potential regulatory changes impacting supplement formulation and compliance across the EU.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Parma, Italy — 29 September 2026
The European Food Safety Authority (EFSA) will convene its 'Safe Food, One Future' conference in September 2027 in Parma, Italy, marking a significant milestone for the European supplement industry. This event is set to critically review 25 years of scientific advice and risk assessment since EFSA's inception in 2002. The focus will span persistent challenges such as climate change, zoonotic diseases, antimicrobial resistance, and emerging risks. This retrospective analysis, coupled with forward-looking discussions among scientific experts and policymakers, strongly indicates a potential recalibration of regulatory priorities and scientific methodologies that will directly influence how novel ingredients are assessed and existing products are regulated within the EU food chain.
For supplement manufacturers, the conference outcome could trigger substantial shifts in acceptable ingredient lists, permissible claim substantiation, and manufacturing best practices. EFSA's historical role as the cornerstone of EU food safety legislation means that any new scientific opinions or updated risk assessment methodologies arising from this gathering are highly likely to translate into legislative amendments by the European Commission, impacting market access and product development timelines. Businesses must prepare for potential increases in dossier submission requirements and heightened scrutiny for ingredients linked to discussed risk areas, such as botanicals susceptible to environmental contaminants or novel food components.
While the conference is less than one year away, its planning underscores a concerted effort to fortify EU food safety frameworks. Proactive engagement with regulatory consultants and internal R&D teams is advised to anticipate changes. Companies that track these discussions closely will gain a competitive advantage, enabling earlier adaptation of product portfolios and supply chain strategies. Neglecting these signals could result in costly reformulation efforts, extended market approval delays, or forced product withdrawals once new guidelines are formalised.
What this means for United Kingdom
Despite Brexit, UK-based supplement manufacturers and brand owners supplying the EU market must align with EFSA-driven regulatory changes. The UK's Food Standards Agency (FSA) often mirrors EFSA guidance for domestic regulations, particularly concerning novel foods and ingredient safety. Companies should monitor the conference's scientific conclusions as these will likely inform future FSA stances, potentially leading to parallel compliance requirements. This necessitates early budget allocation for ingredient testing, potential reformulation, and updated labelling, impacting products sold in both the EU and the UK. Failure to adapt could result in dual market access hurdles and reduced competitive positioning.
This trend is being actively addressed by UK manufacturing partners including Supplement Factory.